|
TOP2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64712687933388E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.07150000170509E-08 |
| Normal-vs-Stage2 |
1.021400E-01 |
| Normal-vs-Stage3 |
2.25779999999398E-05 |
| Normal-vs-Stage4 |
6.038000E-02 |
| Stage1-vs-Stage2 |
5.066800E-01 |
| Stage1-vs-Stage3 |
1.017160E-03 |
| Stage1-vs-Stage4 |
1.076420E-01 |
| Stage2-vs-Stage3 |
8.162500E-02 |
| Stage2-vs-Stage4 |
1.703390E-01 |
| Stage3-vs-Stage4 |
4.614800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.6257995777712E-10 |
| Normal-vs-AfricanAmerican |
8.209200E-04 |
| Normal-vs-Asian |
4.887600E-02 |
| Caucasian-vs-AfricanAmerican |
5.204200E-01 |
| Caucasian-vs-Asian |
5.353200E-01 |
| AfricanAmerican-vs-Asian |
3.176200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.00960034671505E-10 |
| Normal-vs-Female |
2.90420000004232E-06 |
| Male-vs-Female |
2.189600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.202600E-03 |
| Normal-vs-Extreme_Weight |
1.40289999617238E-08 |
| Normal-vs-Obese |
3.82309999999997E-05 |
| Normal-vs-Extreme_Obese |
2.833700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.921700E-02 |
| Normal_Weight-vs-Obese |
9.349200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.093600E-02 |
| Extreme_Weight-vs-Obese |
1.552250E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.488400E-02 |
| Obese-vs-Extreme_Obese |
1.577850E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.380190E-02 |
| Normal-vs-Age(41-60Yrs) |
5.36990000243875E-08 |
| Normal-vs-Age(61-80Yrs) |
9.10290000044611E-07 |
| Normal-vs-Age(81-100Yrs) |
1.041910E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.068410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.125800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.820300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.898300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.476000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.280000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.01116942281033E-12 |
| Normal-VS-Type2 PRCC |
2.363600E-04 |
| Normal-VS-KIRP CIMP |
3.021000E-03 |
| Normal-VS-Unclassified PRCC |
9.89449999999614E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.006000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.377100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.054000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.371860E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.442400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.741800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.563300E-04 |
| Normal-vs-N1 |
1.628660E-04 |
| Normal-vs-N2 |
6.828100E-02 |
| N0-vs-N1 |
2.837900E-03 |
| N0-vs-N2 |
1.157830E-01 |
| N1-vs-N2 |
5.113200E-01 |
|
|
